About Iovance (IOVA)
Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as novel cancer immunotherapy products designed to harness the power of a patient’s own imm... Read more
- USD13.80
- USD14.23
- USD13.75
- USD18.33
- -2.70%
- 1M
- 2.89M
- 4.22M
- 3.8B
- 3.21
- 108.70%
Stock News
2 hours ago
AI Powers This IBD 50 Logistics Leader; Sales Look To Soar 90%
Yahoo
2 hours ago
Jim Cramer Says “Hang On To Stocks” and Recommends 10 Stocks
Yahoo
2 hours ago
Intel Claims It's On Track To Catch Up By 2026 Despite A Lackluster Outlook
Yahoo
2 hours ago
We are trimming a large position to take some profits in this overbought market
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
